ADAP
Adaptimmune Therapeutics
ADAP
ADAP
49 hedge funds and large institutions have $219M invested in Adaptimmune Therapeutics in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 7 closing their positions.
Holders
49
Holders Change
+9
Holders Change %
+22.5%
% of All Funds
1.22%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
16
Increased
13
Reduced
7
Closed
7
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
+$3K